biotechnology

OS Therapies (NYSE: OSTX) is a most cancers immunotherapy firm engaged within the improvement...

Market

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness | AlphaStreet

Eli Lilly and Firm (NYSE: LLY) Thursday reported a pointy improve in its fourth-quarter...

Market

LLY Earnings: Eli Lilly This autumn 2024 revenue greater than doubles; income up 45% | AlphaStreet

Pharmaceutical firm Merck & Co. Inc. (NYSE: MRK) reported a pointy enhance in adjusted...

Market

MRK Earnings: Merck This fall 2024 adj. revenue jumps on sturdy gross sales progress | AlphaStreet

Biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) introduced fourth-quarter 2024 monetary outcomes, reporting a double-digit...

Market

AbbVie This autumn 2024 adjusted earnings decline regardless of 6% income development | AlphaStreet

Gelteq Restricted (NASDAQ: GELS) is a healthcare firm specializing within the improvement and manufacturing...

Market

“Gelteq has been continuously evolving to expand applications and audiences” | AlphaStreet

Depth Therapeutics, Inc. (NASDAQ: INTS) is a medical biotechnology firm engaged within the discovery...

Market

Depth Therapeutics is establishing a brand new discipline of localized most cancers discount: CEO | AlphaStreet

Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings outcomes at present. Complete income...

Market

Key highlights from Biogen’s (BIIB) Q3 2024 earnings outcomes | AlphaStreet

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech firm targeted on shifting new...

Market

Ocean Biomedical (NASDAQ: OCEA) Analysis Abstract | AlphaStreet

Eli Lilly and Firm (NYSE: LLY) on Thursday reported a double-digit improve in revenues...

Market

LLY Earnings: Highlights of Eli Lilly’s Q2 2024 monetary report | AlphaStreet

Pharmaceutical firm Merck & Co. Inc. (NYSE: MRK) reported web revenue for the second...

Market

Merck (MRK) swings to revenue in Q2 on increased revenues; earnings beat | AlphaStreet

Biotechnology firm Bristol Myers Squibb (NYSE: BMY) Friday reported larger revenues and web revenue...

Market

BMY Earnings: Bristol-Myers Squibb reviews larger Q2 income and revenue | AlphaStreet

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a new-generation biotechnology agency that works to speed...

Market

Look up anything

Look up anything

Latest Posts

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness | AlphaStreet

LLY Earnings: Eli Lilly This autumn 2024 revenue greater than doubles; income up 45% | AlphaStreet

MRK Earnings: Merck This fall 2024 adj. revenue jumps on sturdy gross sales progress | AlphaStreet

AbbVie This autumn 2024 adjusted earnings decline regardless of 6% income development | AlphaStreet

“Gelteq has been continuously evolving to expand applications and audiences” | AlphaStreet

Depth Therapeutics is establishing a brand new discipline of localized most cancers discount: CEO | AlphaStreet

Key highlights from Biogen’s (BIIB) Q3 2024 earnings outcomes | AlphaStreet

Ocean Biomedical (NASDAQ: OCEA) Analysis Abstract | AlphaStreet

LLY Earnings: Highlights of Eli Lilly’s Q2 2024 monetary report | AlphaStreet

Merck (MRK) swings to revenue in Q2 on increased revenues; earnings beat | AlphaStreet

BMY Earnings: Bristol-Myers Squibb reviews larger Q2 income and revenue | AlphaStreet

Ocean Biomedical (NASDAQ: OCEA) Analysis Abstract | AlphaStreet – Coin Trolly

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness | AlphaStreet

LLY Earnings: Eli Lilly This autumn 2024 revenue greater than doubles; income up 45% | AlphaStreet

MRK Earnings: Merck This fall 2024 adj. revenue jumps on sturdy gross sales progress | AlphaStreet

AbbVie This autumn 2024 adjusted earnings decline regardless of 6% income development | AlphaStreet

“Gelteq has been continuously evolving to expand applications and audiences” | AlphaStreet

Depth Therapeutics is establishing a brand new discipline of localized most cancers discount: CEO | AlphaStreet

Useful Links

Topics

Top Coins

Join Us